Quantum Biopharma Files Lawsuit Against Banks for Stock Manipulation
Quantum Biopharma, previously known as FSD Pharma, is making waves with a recent update. The company has taken a bold move by filing a US$700 million lawsuit against major financial institutions, including CIBC and RBC. They are accusing these institutions of manipulating stock prices, and are calling on shareholders to join the legal battle.
This legal action aims to not only hold these financial institutions accountable, but also to recover losses for shareholders. Quantum Biopharma has enlisted the help of a contingency-based legal team to strengthen their case and fight for justice.
For those interested in learning more about TSE:QNTM stock, be sure to check out TipRanks’ Stock Analysis page for additional insights.
In other news, some notable stock movements have caught the attention of investors. Insider trade activity, such as Bob Iger selling Walt Disney shares worth over $42 million, and a shareholder alert for Hasbro, Inc. (NASDAQ:HAS), are definitely worth keeping an eye on. Additionally, there are upcoming stock splits to watch out for this week (November 25 to November 29), so staying informed is key for making savvy investment decisions.
Don’t forget to take advantage of TipRanks Premium’s Black Friday offers to unlock your investing potential and receive weekly expert stock picks from the Smart Investor Newsletter. Happy investing!
